Level of leukotrienes B4 and C4 in the blood of patients with periodic disease | Canada Hyperbarics Skip to main content
Study Biull Eksp Biol Med 1990

Level of leukotrienes B4 and C4 in the blood of patients with periodic disease

Gabrielian E, Grigorian S, Davtian D, Mkhitarian G, Panosian A — Biull Eksp Biol Med, 1990

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers measured levels of specific inflammatory markers, leukotrienes B4 and C4, in the blood of patients with Familial Mediterranean Fever (FMF) and observed the effect of hyperbaric oxygenation (HBOT).

What They Found

The study found that patients with Familial Mediterranean Fever had significantly higher levels of LTB4 (53 + 10 pg/ml) and LTC4 (175 + 22 pg/ml) compared to healthy individuals (LTB4: 25 + 5 pg/ml; LTC4: 67 + 19 pg/ml). During fever attacks, these levels increased further to 107 + 21 pg/ml for LTB4 and 249 + 34 pg/ml for LTC4. Hyperbaric oxygenation was observed to reduce these elevated leukotriene levels, which was associated with pain and fever relief.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This study was published in 1990 and provides limited details on its methodology, sample size, or specific HBOT protocols used.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Study
Category Uncategorised
Source Pubmed
PubMed ID 2176555
Year Published 1990
Journal Biull Eksp Biol Med
MeSH Terms Colchicine; Familial Mediterranean Fever; Humans; Hyperbaric Oxygenation; Leukotriene B4; SRS-A

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology